The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons

被引:25
作者
Janssen, George M. C.
Hensbergen, Paul J.
van Bussel, Frans J.
Balog, Crina I. A.
Maassen, J. Antonie
Deelder, Andre M.
Raap, Anton K.
机构
[1] Leiden Univ, Ctr Med, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Ctr Med, Biomol Mass Spectrometry Unit, Dept Parasitol, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1093/hmg/ddm203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the mitochondrial tRNA (Leu( UUR)) gene are associated with a large variety of human diseases through a largely undisclosed mechanism. The A3243G tRNA (Leu(UUR)) mutation leads to reduction of mitochondrial DNA (mtDNA)-encoded proteins and oxidative phosphorylation activity even when the cells are competent in mitochondrial translation. These two aspects led to the suggestion that a dominant negative factor may underlie the diversity of disease expression. Here we test the hypothesis that A3243G tRNA Leu( UUR) generates such a dominant negative gain-of-function defect through misincorporation of amino acids at UUR codons of mtDNA-encoded proteins. Using an anti-complex IV immunocapture technique and mass spectrometry, we show that the mtDNA- encoded cytochrome c oxidase I (COX I) and COX II exist exclusively with the correct amino acid sequences in A3243G cells in a misassembled complex IV. A dominant negative component therefore cannot account for disease phenotype, leaving tissue-specific accumulation by mtDNA segregation as the most likely cause of variable mitochondrial disease expression.
引用
收藏
页码:2472 / 2481
页数:10
相关论文
共 57 条
[31]   Focused proteomics: towards a high throughput monoclonal antibody-based resolution of proteins for diagnosis of mitochondrial diseases [J].
Murray, J ;
Yonally, S ;
Aggeler, R ;
Marusich, MF ;
Capaldi, RA .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2004, 1659 (2-3) :206-211
[32]   CHANNELING OF AMINOACYL-TRANSFER RNA FOR PROTEIN-SYNTHESIS INVIVO [J].
NEGRUTSKII, BS ;
DEUTSCHER, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4991-4995
[33]   Assembly of cytochrome-c oxidase in cultured human cells [J].
Nijtmans, LGJ ;
Taanman, JW ;
Muijsers, AO ;
Speijer, D ;
Van den Bogert, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 254 (02) :389-394
[34]   EXPRESSION AND FATE OF THE NUCLEARLY ENCODED SUBUNITS OF CYTOCHROME-C-OXIDASE IN CULTURED HUMAN-CELLS DEPLETED OF MITOCHONDRIAL GENE-PRODUCTS [J].
NIJTMANS, LGJ ;
SPELBRINK, JN ;
VANGALEN, MJM ;
ZWAAN, M ;
KLEMENT, P ;
VANDENBOGERT, C .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1265 (2-3) :117-126
[35]   Single muscle fiber analysis in patients with 3243 mutation in mitochondrial DNA: Comparison with the phenotype and the proportion of mutant genome [J].
Ozawa, M ;
Nonaka, I ;
Goto, Y .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 159 (02) :170-175
[36]   The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation [J].
Park, H ;
Davidson, E ;
King, MP .
BIOCHEMISTRY, 2003, 42 (04) :958-964
[37]   The tRNA-binding moiety in GCN2 contains a dimerization domain that interacts with the kinase domain and is required for tRNA binding and kinase activation [J].
Qiu, H ;
Dong, J ;
Hu, C ;
Francklyn, CS ;
Hinnebusch, AG .
EMBO JOURNAL, 2001, 20 (06) :1425-1438
[38]   Comparative proteomics as a new tool for exploring human mitochondrial tRNA disorders [J].
Rabilloud, T ;
Strub, JM ;
Carte, N ;
Luche, S ;
Van Dorsselaer, A ;
Lunardi, J ;
Giegé, R ;
Florentz, C .
BIOCHEMISTRY, 2002, 41 (01) :144-150
[39]   DIABETES-MELLITUS ASSOCIATED WITH A PATHOGENIC POINT MUTATION IN MITOCHONDRIAL-DNA [J].
REARDON, W ;
ROSS, RJM ;
SWEENEY, MG ;
LUXON, LM ;
PEMBREY, ME ;
HARDING, AE ;
TREMBATH, RC .
LANCET, 1992, 340 (8832) :1376-1379
[40]   Impairment of tRNA processing by point mutations in mitochondrial tRNALeu(UUR) associated with mitochondrial diseases [J].
Rossmanith, W ;
Karwan, RM .
FEBS LETTERS, 1998, 433 (03) :269-274